Product
Supplier
Encyclopedia
Inquiry
Home > News > Valuable News > Dr. Reddy's Gets EIR from USFDA for UK Plant

Dr. Reddy's Gets EIR from USFDA for UK Plant

Chemical Weekly 2018-05-17

Dr. Reddy’s Laboratories has received an establishment inspection report (EIR) from the US health regulator after audit of its UK API facility. “With regard to the audit of our API Mirfield plant, United Kingdom, we would now like to inform that we have received an establishment inspection report (EIR) from the USFDA, indicating closure of the audit,” Dr. Reddy’s said in a regulatory filing. The USFDA issues an EIR to the establishment that is the subject of an FDA or FDA-contracted inspection when the agency decides to close the inspection. In September last year, the US health regulator had made three observations after inspecting the API Mirfield plant.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.